Unknown

Dataset Information

0

Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition.


ABSTRACT: A series of 24 compounds was synthesised based on a 2-cyclopentyloxyanisole scaffold 3-14 and their in vitro antitumor activity was evaluated. Compounds 4a, 4b, 6b, 7b, 13, and 14 had the most potent antitumor activity (IC50 range: 5.13-17.95 μM), compared to those of the reference drugs celecoxib, afatinib, and doxorubicin. The most active derivatives 4a, 4b, 7b, and 13 were evaluated for their inhibitory activity against COX-2, PDE4B, and TNF-α. Compounds 4a and 13 potently inhibited TNF-α (IC50 values: 2.01 and 6.72 μM, respectively) compared with celecoxib (IC50=6.44 μM). Compounds 4b and 13 potently inhibited COX-2 (IC50 values: 1.08 and 1.88 μM, respectively) comparable to that of celecoxib (IC50=0.68 μM). Compounds 4a, 7b, and 13 inhibited PDE4B (IC50 values: 5.62, 5.65, and 3.98 μM, respectively) compared with the reference drug roflumilast (IC50=1.55 μM). The molecular docking of compounds 4b and 13 with the COX-2 and PDE4B binding pockets was studied.HighlightsAntitumor activity of new synthesized cyclopentyloxyanisole scaffold was evaluated.The powerful antitumor 4a, 4b, 6b, 7b & 13 were assessed as COX-2, PDE4B & TNF-α inhibitors.Compounds 4a, 7b, and 13 exhibited COX-2, PDE4B, and TNF-α inhibition.Compounds 4b and 13 showed strong interactions at the COX-2 and PDE4B binding pockets.

SUBMITTER: El-Husseiny WM 

PROVIDER: S-EPMC7144195 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition.

El-Husseiny Walaa M WM   El-Sayed Magda A-A MA   El-Azab Adel S AS   AlSaif Nawaf A NA   Alanazi Mohammed M MM   Abdel-Aziz Alaa A-M AA  

Journal of enzyme inhibition and medicinal chemistry 20201201 1


A series of 24 compounds was synthesised based on a 2-cyclopentyloxyanisole scaffold <b>3-14</b> and their <i>in vitro</i> antitumor activity was evaluated. Compounds <b>4a</b>, <b>4b</b>, <b>6b</b>, <b>7b</b>, <b>13</b>, and <b>14</b> had the most potent antitumor activity (IC<sub>50</sub> range: 5.13-17.95 μM), compared to those of the reference drugs celecoxib, afatinib, and doxorubicin. The most active derivatives <b>4a</b>, <b>4b</b>, <b>7b</b>, and <b>13</b> were evaluated for their inhibi  ...[more]

Similar Datasets

| S-EPMC9048702 | biostudies-literature
| S-EPMC6222829 | biostudies-literature
| S-EPMC7408124 | biostudies-literature
| S-EPMC6359172 | biostudies-literature
| S-EPMC7321323 | biostudies-literature
| S-EPMC5362474 | biostudies-literature
| S-EPMC10535307 | biostudies-literature
| S-EPMC5643734 | biostudies-literature
| S-EPMC8780855 | biostudies-literature
| S-EPMC9294463 | biostudies-literature